Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Genisphere
AddedFeb 15, 2024
UpdatedJun 18, 2026
Genisphere

Genisphere

Series A

Genisphere, a nanotechnology firm, offers innovative tools for targeted drug delivery, clinical diagnostics, and life science research.

HQ
Hatfield, PA, US
Founded
1997
Overview
Compare
Fundraising
Employees

Genisphere is a nanotechnology firm focused on providing innovative tools for targeted drug delivery, clinical diagnostics, and life science research. Leveraging its proprietary 3DNA nanoparticle platform, the company enhances sensitivity in immunoassay and nucleic acid detection platforms while delivering therapeutics with high specificity. Genisphere has successfully out-licensed several reagent kits to the research market.

Genisphere's 3DNA technology has broad applicability, significantly impacting the fields of diagnostics and therapeutics. The company's advancements have led to improved clinical outcomes and research capabilities. Notable achievements include the successful commercialization of its reagent kits, contributing to its reputation as a leader in nanotechnology-driven solutions.

Genisphere - Similar Companies

Nanotransfer logo

Nanotransfer

nanotransfer.bio

Nanoscope Technologies logo

Nanoscope Technologies

Crystalplex logo

Crystalplex

Advanced NanoTherapies logo

Advanced NanoTherapies

NanoHybrids logo

NanoHybrids

nanohybrids.net

Nanogen logo

Nanogen

nanogen.com

Nanopath logo

Nanopath

nanopathdx.com

Ceres Nanosciences logo

Ceres Nanosciences

ceresnano.com

Optimeos Life Sciences logo

Optimeos Life Sciences

optimeos.com

Atom Bioworks logo

Atom Bioworks

atombioworks.com

NX Pharmagen logo

NX Pharmagen

nxpharmagen.com

NuProbe logo

NuProbe

nuprobe.com

INanoBio logo

INanoBio

inanobio.com

Spheringenics logo

Spheringenics

NanoEngineering logo

NanoEngineering

Genisphere - Quick Facts

Who are Genisphere's competitors?

Companies similar to Genisphere include Nanotransfer, Nanoscope Technologies, Crystalplex and Advanced NanoTherapies.

When was Genisphere founded?

Genisphere was founded in 1997.

Where is Genisphere's headquarters located?

Genisphere's headquarters is located in Hatfield, PA, US.

When was Genisphere's last funding round?

Genisphere's most recent funding round was for $4M (USD) in October 2015.

How much has Genisphere raised to-date?

As of Oct 1, 2015, Genisphere has raised a total of $6M (USD).

How many employees does Genisphere have?

Genisphere has 9 employees as of Feb 5, 2024.

Genisphere - Classification

Ownership
  • Private
Technology
  • Nanotechnology
Geographic Exposure
  • Global
Revenue
  • Licensing
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
  • Government
Main Product
  • Diagnostics
  • Drug Delivery
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 3250Manufacture of medical and dental instruments and supplies
Show 20 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 339100Medical Equipment and Supplies Manufacturing
  • 339110Medical Equipment and Supplies Manufacturing
  • 339112Surgical and Medical Instrument Manufacturing
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 339000Miscellaneous Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 3840Surgical, Medical, And Dental Instruments And Supplies
  • 3841Surgical And Medical Instruments And Apparatus
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified